Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Low Doses of Roxadustat Plus Iron in Anemia of Dialysis-dependent CKD
NCT06115421Phase 4Completed
- Sponsor
- Alexandria University
- Start
- May 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of roxadustat in anemia (2 arms), sponsored by Alexandria University. Primary endpoints: Changes in hemoglobin level from baseline at 3 months, Iron metabolism parameters change from the baseline at 3 months and 1 more. Started May 2023; status: completed.
02
Drugs
roxadustat
03
Conditions
anemia
Beyond the preview
Go deeper on NCT06115421.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06115421.